Profile of continuous medical treatment in oncologic patient

Authors

DOI:

https://doi.org/10.33448/rsd-v10i6.15481

Keywords:

Medicine; Cancer; Chronic disease; Patient.

Abstract

Goal: Describe the profile of continuous medical treatment in oncologic patient assisted in a CACON. Method: A Cross-sectional study, analytical and quantitative. The sample is constituted by patients diagnosed  with cancer, inserted to begin oncologic treatment at the High Complexity Center (CACON), evaluated in the period of August, 2018 and January, 2019. Results: Two hundred seventy patients participated in the research, fifty- three percent were of female gender and fifty-one point one percent over sixty years old. It was found asssociation between the use of the medicament and: female sex (p=0.025); be married or have a companion (p=0.049); and over sixty years old (p=0.000). The most used medicament group by oncologic patients in treatment with continuous medicine was the cardiovascular system (69.56%). It was verified the association between using continuous medicine and self-reporting of: hypertension (p=0.000); diabetes mellitus (p=0.013); acute myocardial infarction (p=0.045); depression (p=0.001) and alcoholic drinks (p=0.000). Conclusion: It is important to know the treatment profile of the continuous medicine users in oncologic treatment to ensure the patients safety and the effectiveness of the treatment.

References

Appiani, F., Brendan, T. C., Munoz, C., & Trecco, J. Tamoxifen-SSIRs interaction: Clinical manifestations of inhibition and lack of inhibition os CYP2D6. Ann Oncol. 2011;23(2):152-153.

Arrais PSD, Brito LL, Barreto ML, Coelho HL. Prevalência e fatores determinantes do consumo de medicamentos no Município de Fortaleza, Ceará, Brasil. Cad Saúde Pública. 2005;21(6):1737-46.

Bertoldi, A. D., Pizzol, T. S. D., Ramos, L. R., Mengue, S. S., Luiza, V. L., Tavares, N. U. L., Farias, M. R., Oliveira, M. A., & Arrais, P. S. D. (2016).Perfil sociodemográfico dos usuários de medicamentos no Brasil: resultado do PNAUM 2014. Revista Saúde Pública, 50(2).

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492.

Breitbart W. Do antidepressants reduce the effectiveness of tamoxifen? Psychooncology. 2010;20(1):1-4.

Carneiro, J. A., Cardoso, R. R., Durães, M. S., Guedes, M. C. A., Santos, F. L., Costa, F. M., et al. Frailty in the elderly: prevalence and associated factors. Rev Bras Enferm. 70(4):747-52.

Carvalho, M. F., Pascom, A. N. P., Souza Júnior, P. R. B., Damacena, G. N., & Szwarcwald, C. L.(2005). Utilization of medicines by the Brazilian population, 2003. Cad Saúde Pública, 21(1)100-8.

Malta, D. C., & Silva Júnior, J. B. (2013). O plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil e a definição das metas globais para o enfrentamento dessas doenças até 2025: uma revisão. Epidemiol Serv Saúde, 22(1)151-64.

Medscape. [Internet]. Drug Interaction Checker. https://reference.medscape.com/drug-interactionchecker .

Mendes, E. V. (2011). As redes de atenção à saúde. Brasília-DF: Organização Pan-Americana da Saúde, 549.

Mendes, L. V., Emmerick, I. C. M., & Luiza, V. L. (2014). Uso de medicamentos entre portadores de doenças crônicas: um estudo observacional no estado do Espírito Santo. Rev. Bras. Farm, 95(2):732-947.

Micromedex Healthcare. [Internet]. Drugdex System. Greenwood Village: Series 20: Interactions, 2011. http://www.biblioteca.ufrgs.br/bases.

Micromedex. [Internet] Greenwood Village, Colorado, USA; c1974-2012. http://www.thomsonhc.com.

Oliveira, F. O., Oliveira, C. S., Andrade, J. S., Santos, T. F. C., & Oliveira Barreto, A. C.(2016). Cancer treatment in determination of hearing loss. Rev Bras Otorrinolaringol, 82(1):65-9.

Organização Mundial da Saúde. (2013). Doenças crônicas não transmissíveis. https://www.paho.org/bra/index.php?option=com_conte nt&view=article&id=4766:doencas-cronicas-nao-transmissiveis-causam-16-milhões-de-mortes-prematuras-todos-os-anos &Itemid=839.

Sales, J. T. O. L., Nova, T. C. A., Lopes, I. M., Wanderley, C. M. S., Bezerra, M.R., Farias, I. M. N. & Mello, M. J. G. (2019). Epidemiologia da polifarmácia em idosos oncológicos: estudo de coorte prospectivo. http://higia.imip.org.br/handle/123456789/358.

Santana RM. Abordagem teórica sobre o uso de medicamentos antidepressivos por pacientes em terapia antineoplásica. [Internet] Governador Mangabeira/BA, 2018http://131.0.244.66:8082/jspui/bitstream/123456789/739/1/Rogelly%20Malta%20de%20Santana.pdf.

Santos, M. A., Prado, M. A. S., Panobianco, M. S., & Almeida, A. M. (2011). Grupo de apoio a mulheres mastectomizadas: Cuidando das dimensões subjetivas do adoecer. Revista da SPAGESP, 12(2), 27-33.

Schmidt, M. I., Duncan, B. B., Azevedo e Silva, G., Menezes, A. M., Monteiro, C.A., Barreto, S., Chor, D., & Menezes, P.R. (2011). Chronic non-communicable diseases in Brazil: burden and current challenges. The Lancet, 377,1949-61.

Secoli, S. R. (2010). Polifarmácia: interações e reações adversas no uso de medicamentos por idosos. Rev. Bras. Enferm, 63(1):136-140.

Sereno, V. M. B., Silva, A. S., & Silva, C. V. (2020) Perfil epidemiológico das intoxicações por medicamentos no Brasil entre os anos de 2013 a 2017. Brazilian Journal of Development, 6(6), 33892-33903. https://doi.org/10.34117/bjdv6n6-079.

Silva, G. O. B., Gondim, A. P. S., Monteiro, M. P., Frota, M. A., & Meneses, A. L. L. (2012). Uso de medicamentos contínuos e fatores associados em idosos de Quixadá, Ceará. Rev Bras. Epidemol, 15(2):386-95.

Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: a cancer journal for clinicians, 65(2), 87–108. https://doi.org/10.3322/caac.21262.

World Health Organization. (2003). Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. https://www.who.int/chp/knowledge/publications/adherence_report/en/.

World Health Organization. (2016) Anatomical Therapeutic Chemical. http://www.whocc.no/atc_ddd_index/.

Downloads

Published

31/05/2021

How to Cite

LORENZ, C. .; MONTAGNER, S. D.; STUMM, E. M. F.; SILVA, J. A. G. da; KRAUSE, L. S. .; FACHINETTO , J. M. .; COLET, C. Profile of continuous medical treatment in oncologic patient. Research, Society and Development, [S. l.], v. 10, n. 6, p. e34010615481, 2021. DOI: 10.33448/rsd-v10i6.15481. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/15481. Acesso em: 16 nov. 2024.

Issue

Vol. 10 No. 6

Section

Health Sciences

License

Copyright (c) 2021 Camile Lorenz; Sandra Drews Montagner; Eniva Miladi Fernandes Stumm; Jose Antônio Gonsales da Silva; Lenara Schalanski Krause; Juliana Maria Fachinetto ; Christiane Colet

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.